查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球虫媒病毒测试市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按测试类型、按最终用户、按地区
市场调查报告书
商品编码
1394139

全球虫媒病毒测试市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按测试类型、按最终用户、按地区

Arbovirus Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 172 Pages | 商品交期: 2-5个工作天内

价格
简介目录

预计 2024 年至 2031 年预测期内，全球虫媒病毒检测市场规模将显着成长。 虫媒病毒主要透过蚊子和蜱虫等受感染的节肢动物传播给人类，由于其对公共卫生的影响而受到越来越多的关注。

全球虫媒病毒检测市场的成长取决于多种因素，例如虫媒病毒的快速出现、日益严峻的公共卫生挑战以及政府综合措施的实施。 这些驱动因素共同促进了虫媒病毒检测市场在全球范围内的成长和扩张。

公共卫生实验室处于世界各地虫媒病毒检测的最前线。 就价值而言，公共卫生实验室部分是最大的，预计在整个评估期间将保持这一地位。 其显着的收入创造为虫媒病毒检测市场的整体成长做出了重大贡献。

最终用户类别中的医院细分市场预计将显着成长，并且是价值最高的细分市场之一。 儘管成长率相对温和，但预计会大幅扩张，反映出医院在虫媒病毒检测方面日益重要。

本报告考察了全球虫媒病毒检测市场，并提供了市场概述，包括按检测类型、最终用户、地区划分的趋势以及进入市场的公司的竞争趋势。

目录

第 1 章执行摘要

第二章市场概述

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影响分析
  • 乌克兰和俄罗斯之间衝突的影响
  • 经济概况
  • 杵分析

第 3 章全球虫媒病毒检测市场前景，2018-2031

  • 2018-2031 年全球虫媒病毒检测市场展望（按检测类型、价值（十亿美元））
  • 2018-2031 年全球虫媒病毒检测市场前景（按最终用户划分）价值（十亿美元）
  • 2018-2031 年全球虫媒病毒检测市场前景（按地区、价值（十亿美元））

第 4 章北美虫媒病毒检测市场前景，2018-2031

第五章欧洲虫媒病毒检测市场前景，2018-2031

第 6 章亚太地区虫媒病毒检测市场展望，2018-2031 年

第 7 章拉丁美洲虫媒病毒检测市场展望，2018-2031 年

第 8 章中东与非洲虫媒病毒检测市场前景，2018-2031 年

第九章竞争态势

  • 製造商和最终用户的热图
  • 2023 年公司市占率分析
  • 竞争力仪表板
  • 公司简介
    • Thermo Fisher Scientific, Inc.
    • Diamedix Corporation
    • NovaTec Immundiagnostica GmbH
    • Euroimmun AG
    • Focus Diagnostics (Member of DiaSorin Group)
    • Standard Diagnostics, Inc.
    • IBL International (A Member of the Tecan Group) Alere

第 10 章附录

简介目录

The global market for arbovirus testing is poised for substantial growth over the forecast period from 2024 to 2031, according to a comprehensive market study. Arboviruses, which are primarily transmitted to humans through infected arthropods like mosquitoes and ticks, have gained increasing attention due to their public health impact. The research report delves into the latest trends, opportunities, drivers, and challenges influencing the market, offering valuable insights for industry stakeholders.

Expanding Horizons in Arbovirus Testing

The scope of this research encompasses a thorough analysis of end-user preferences, competitive dynamics, regional outlook, and various test types within arbovirus testing. Asia-Pacific and Middle East & Africa emerge as promising markets, driven by their substantial populations at risk of arbovirus infections and high arbovirus prevalence. Manufacturers are focused on advancing diagnostic techniques, extending their applicability beyond a few infections, thereby fueling market growth.

Key Drivers of Growth

The growth of the global arbovirus testing market hinges on several factors, including the rapid emergence of arboviruses, increasing public health challenges, and the implementation of integrated government initiatives. These drivers collectively contribute to the growth and expansion of the arbovirus testing market on a global scale.

Dominance of Public Health Laboratories

Public health laboratories have been at the forefront of arbovirus testing efforts worldwide. In terms of value, the public health laboratory segment is the largest and is expected to maintain this position throughout the assessment period. Its remarkable revenue generation significantly contributes to the overall growth of the arbovirus testing market.

Hospitals on the Rise

The hospital segment within the end-user category is anticipated to experience substantial growth, positioning itself as one of the top segments in terms of value. Despite a comparatively slower growth rate, it is projected to expand noticeably, reflecting the increasing importance of hospitals in arbovirus testing.

Market Segmentation

The market segmentation for the arbovirus testing industry includes test types, end users, and regions:

By Test Type:

  • 1. ELISA-Based Tests
  • 2. RT-PCR Based Tests

By End User:

  • 1. Hospitals
  • 2. Public Health Laboratories
  • 3. Diagnostic Centers
  • 4. Others

By Region:

  • 1. North America
  • 2. Latin America
  • 3. Europe
  • 4. Asia Pacific (APAC)
  • 5. Middle East and Africa (MEA)

The global arbovirus testing market is set to witness significant growth and innovation in the coming years, with a range of opportunities and challenges for businesses in this sector. Stakeholders, including manufacturers, healthcare providers, and public health agencies, are gearing up to address the growing threat of arbovirus infections and contribute to the advancement of diagnostic capabilities.

Table of Contents

1. Executive Summary

  • 1.1. Global Arbovirus Testing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Arbovirus Testing Market Outlook, 2018 - 2031

  • 3.1. Global Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. ELISA-Based Tests
      • 3.1.1.2. RT-PCR Based Tests
  • 3.2. Global Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Hospitals
      • 3.2.1.2. Public Health Laboratory
      • 3.2.1.3. Diagnostic Centers
      • 3.2.1.4. Others
  • 3.3. Global Arbovirus Testing Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Arbovirus Testing Market Outlook, 2018 - 2031

  • 4.1. North America Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. ELISA-Based Tests
      • 4.1.1.2. RT-PCR Based Tests
  • 4.2. North America Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Hospitals
      • 4.2.1.2. Public Health Laboratory
      • 4.2.1.3. Diagnostic Centers
      • 4.2.1.4. Others
    • 4.2.2. BPS Analysis/Market Attractiveness Analysis
  • 4.3. North America Arbovirus Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 4.3.1.2. U.S. Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 4.3.1.3. Canada Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 4.3.1.4. Canada Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Arbovirus Testing Market Outlook, 2018 - 2031

  • 5.1. Europe Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. ELISA-Based Tests
      • 5.1.1.2. RT-PCR Based Tests
  • 5.2. Europe Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Hospitals
      • 5.2.1.2. Public Health Laboratory
      • 5.2.1.3. Diagnostic Centers
      • 5.2.1.4. Others
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Europe Arbovirus Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.2. Germany Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.3. U.K. Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.4. U.K. Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.5. France Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.6. France Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.7. Italy Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.8. Italy Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.9. Turkey Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.10. Turkey Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.11. Russia Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.12. Russia Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.13. Rest of Europe Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.14. Rest of Europe Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Arbovirus Testing Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. ELISA-Based Tests
      • 6.1.1.2. RT-PCR Based Tests
  • 6.2. Asia Pacific Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Hospitals
      • 6.2.1.2. Public Health Laboratory
      • 6.2.1.3. Diagnostic Centers
      • 6.2.1.4. Others
    • 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Arbovirus Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.2. China Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.3. Japan Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.4. Japan Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.5. South Korea Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.6. South Korea Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.7. India Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.8. India Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.9. Southeast Asia Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.10. Southeast Asia Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Arbovirus Testing Market Outlook, 2018 - 2031

  • 7.1. Latin America Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. ELISA-Based Tests
      • 7.1.1.2. RT-PCR Based Tests
  • 7.2. Latin America Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
      • 7.2.1.1. Hospitals
      • 7.2.1.2. Public Health Laboratory
      • 7.2.1.3. Diagnostic Centers
      • 7.2.1.4. Others
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Arbovirus Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.2. Brazil Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.3.1.3. Mexico Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.4. Mexico Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.3.1.5. Argentina Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.6. Argentina Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Arbovirus Testing Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. ELISA-Based Tests
      • 8.1.1.2. RT-PCR Based Tests
  • 8.2. Middle East & Africa Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Hospitals
      • 8.2.1.2. Public Health Laboratory
      • 8.2.1.3. Diagnostic Centers
      • 8.2.1.4. Others
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Arbovirus Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.2. GCC Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.3.1.3. South Africa Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.4. South Africa Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.3.1.5. Egypt Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.6. Egypt Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.3.1.7. Nigeria Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.8. Nigeria Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Manufacturer vs by End User Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific, Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Diamedix Corporation
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. NovaTec Immundiagnostica GmbH
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Euroimmun AG
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Focus Diagnostics (Member of DiaSorin Group)
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Standard Diagnostics, Inc.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. IBL International (A Member of the Tecan Group)
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Alere
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations